Erythropoietin Treatment in Extremely Low Birth Weight Infants

NACompletedINTERVENTIONAL
Enrollment

219

Participants

Timeline

Start Date

May 31, 1998

Primary Completion Date

June 30, 1999

Study Completion Date

June 30, 1999

Conditions
Infant, Low Birth WeightAnemia
Interventions
DRUG

epoetin beta

250 IU/kg/week rhEPO treatment subcutaneously 3 times a week from the first week for 9 weeks, all infants received enteral iron 3-9 mg/kg/day

DRUG

epoetin beta

250 IU/kg/week subcutaneously 3 times a week, from the fourth week for 6 weeks, all infants received enteral iron 3-9 mg/kg/day

Trial Locations (1)

13353

Dept of Neonatolgy Charité University Medicine Berlin, Berlin

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

University Hospital Tuebingen

OTHER

collaborator

Children's Hospital at the Bult Hannover, Germany

UNKNOWN

collaborator

University Hospital, Aachen

OTHER

collaborator

University of Zurich

OTHER

collaborator

Children's Hospital Koeln, Germany

UNKNOWN

collaborator

Université Catholique de Louvain

OTHER

collaborator

Children's Hospital Dortmund, Germany

UNKNOWN

collaborator

Hopital Antoine Beclere

OTHER

collaborator

Hôpital Edouard Herriot

OTHER

collaborator

Olga Hospital Stuttgart, Germany

UNKNOWN

collaborator

University Hospital, Strasbourg, France

OTHER

lead

Charite University, Berlin, Germany

OTHER

NCT00593801 - Erythropoietin Treatment in Extremely Low Birth Weight Infants | Biotech Hunter | Biotech Hunter